Calumenin antibody
Principal name
Calumenin antibody
Alternative names for Calumenin antibody
Crocalbin, IEF SSP 9302
Ncbi ID
9606, NP_001210, NP_001124146, NP_001124146.1, NP_001210.1, NP_031620.1, NM_007594, NM_184053, NM_001219, NM_001130674
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Enzyme Immunoassay (E)
Background of Calumenin antibody
- Kit Component:
- - KN302472G1, Calu gRNA vector 1 in pCas-Guide vector
- KN302472G2, Calu gRNA vector 2 in pCas-Guide vector
- KN302472D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Yabe D., et al. (1997) J Biol Chem. 272(29):18232-9.
Vorum H., et al. (1998) Biochim Biophys Acta. 1386(1):121-31.

Immunofluorescence of purified MaxPab antibody to CALU on HeLa cell. [antibody concentration 10 ug/ml]

Western Blot analysis of CALU expression in transfected 293T cell line (H00000813-T02) by CALU MaxPab polyclonal antibody.Lane 1: CALU transfected lysate(34.65 KDa).Lane 2: Non-transfected lysate.

Human U937; WB Suggested Anti-CALU Antibody. . Titration: 1.0 ug/ml. . Positive Control: U937 Whole Cell; CALU antibody - C-terminal region (ARP61636_P050) in Human U937 cells using Western Blot

CALU Antibody (C-term) (Cat. #AP50717PU-N)immunohistochemistry analysis in formalin fixed and paraffin embedded human placenta tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of CALU Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.

CALU Antibody (C-term) (Cat. #AP50717PU-N) western blot analysis in NCI-H292 cell line lysates (35µg/lane).This demonstrates the CALU antibody detected the CALU protein (arrow).
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA346899 | Calumenin antibody |
||||||
| Mouse Monoclonal Calumenin Antibody | |||||||
![]() |
Mouse | IgG1 | 4C6-G10-B12 | Purified | WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP50717PU-N | Calumenin (C-term) antibody |
||||||
![]() |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN200589 | CALU - human gene knockout kit via CRISPR |
||
![]() |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN200589BN | CALU - human gene knockout kit via CRISPR |
||
![]() |
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN200589LP | CALU - human gene knockout kit via CRISPR |
||
![]() |
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN200589RB | CALU - human gene knockout kit via CRISPR |
||
![]() |
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP300589 | Calumenin (transcript variant 1) |
||||
| Recombinant protein of human calumenin (CALU), transcript variant 1 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP720752 | Calumenin (transcript variant 1) |
||||
| Purified recombinant protein of Human calumenin (CALU), transcript variant 1 | |||||
![]() |
Human | > 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
10 µg /
€299.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR204503L2V | Lenti ORF particles, Calu (GFP-tagged) - Mouse calumenin (Calu), transcript variant 1, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR219228L2V | Lenti ORF particles, Calu (GFP-tagged) - Mouse calumenin (Calu), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR204503L1V | Lenti ORF particles, Calu (Myc-DDK-tagged) - Mouse calumenin (Calu), transcript variant 1, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
| MR219228L1V | Lenti ORF particles, Calu (Myc-DDK-tagged) - Mouse calumenin (Calu), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||






+1 additional image
